期刊的影响因子--文章列表

期刊文章列表
Kun Luo，Wenting Huang，Liansheng Qiao，Xiaoling Zhang，Di Yan，Zhiyu Ning，Chengmei Ma，Honglei Dang，Dong Wang，Hongyan Guo，Lan Xie，Jing Cheng（State Key Laboratory of Membrane Biology，School of Medicine，Tsinghua University，Beijing 100084，China；Medical Systems Biology Research Center School of Medicine，Tsinghua University，Beijing 100084，China；National Engineering Research Center for Beijing Biochip Technology，Beijing 102206，China；School of Basic Medical Sciences，Chengdu University of Traditional Chinese Medicine，Chengdu 611137，China；State Key Laboratory of Membrane Biology，School of Medicine，Tsinghua University，Beijing 100084，China；Medical Systems Biology Research Center School of Medicine，Tsinghua University，Beijing 100084，China；National Engineering Research Center for Beijing Biochip Technology，Beijing 102206，China；State Key Laboratory of Membrane Biology，School of Medicine，Tsinghua University，Beijing 100084，China；Medical Systems Biology Research Center School of Medicine，Tsinghua University，Beijing 100084，China；National Engineering Research Center for Beijing Biochip Technology，Beijing 102206，China；School of Basic Medical Sciences，Chengdu University of Traditional Chinese Medicine，Chengdu 611137，China）.Dendrocalamus latiflorus and its component rutin exhibit glucose-lowering activities by inhibiting hepatic glucose production via AKT activation[J].药学学报(英文版),2022,第5期 Chan Feng，Yongjiang Li，Bijan Emiliano Ferdows，Dylan Neal Patel，Jiang Ouyang，Zhongmin Tang，Na Kong，Enguo Chen，Wei Tao（Department of Respiratory Medicine，Sir Run Run Shaw Hospital，Zhejiang University School of Medicine，Hangzhou 310016，China；Center for Nanomedicine and Department of Anesthesiology，Brigham and Women，s Hospital，Harvard Medical School，Boston，MA 02115，USA；Cancer Center，Zhejiang University，Hangzhou 310058，China；Center for Nanomedicine and Department of Anesthesiology，Brigham and Women，s Hospital，Harvard Medical School，Boston，MA 02115，USA；Department of Pharmacy，the Second Xiangya Hospital of Central South University，Changsha 410011，China；Center for Nanomedicine and Department of Anesthesiology，Brigham and Women，s Hospital，Harvard Medical School，Boston，MA 02115，USA；Department of Respiratory Medicine，Sir Run Run Shaw Hospital，Zhejiang University School of Medicine，Hangzhou 310016，China；Cancer Center，Zhejiang University，Hangzhou 310058，China）.Emerging vaccine nanotechnology：From defense against infection to sniping cancer[J].药学学报(英文版),2022,第5期 Weimin Yu，Gang Xu，Hui Chen，Li Xiao，Gang Liu，Pingping Hu，Siqi Li，Vivi Kasim，Chunyu Zeng，Xiaoyong Tong（School of Pharmaceutical Sciences，Chongqing University，Chongqing 401331，China；Institute of Health Biological Chemical Medication，Chongqing Institute of Green and Intelligent Technology，Chinese Academy of Sciences，Chongqing 400714，China；Institute of Medicine and Equipment for High Altitude Region，College of High Altitude Military Medicine，Army Medical University(Third Military Medical University)，Chongqing 400038，China；Key Laboratory of High Altitude Medicine，People's Liberation Army，Chongqing 400038，China；School of Pharmaceutical Sciences，Chongqing University，Chongqing 401331，China；School of Pharmaceutical Sciences，Chongqing University，Chongqing 401331，China；Henan Key Laboratory of Medical Tissue Regeneration，College of Basic Medical Sciences，Xinxiang Medical University，Xinxiang 453003，China；Key Laboratory of Biorheological Science and Technology，Ministry of Education，College of Bioengineering，Chongqing University，Chongqing 400044，China；Department of Cardiology，Doping Hospital，Army Medical University(Third Military Medical University)，Chongqing 400042，China）.The substitution of SERCA2 redox cysteine 674 promotes pulmonary vascular remodeling by activating IRE1α/XBP1s pathway[J].药学学报(英文版),2022,第5期 Shuzhen Chen，Yaping Dong，Xinming Qi，Qiqi Cao，Tao Luo，Zhaofang Bai，Huisi He，Zhecai Fan，Lingyan Xu，Guozhen Xing，Chunyu Wang，Zhichao Jin，Zhixuan Li，Lei Chen，Yishan Zhong，Jiao Wang，Jia Ge，Xiaohe Xiao，Xiuwu Bian，Wen Wen，Jin Ren，Hongyang Wang（National Center for Liver Cancer，Second Military Medical University，Shanghai 200438，China；International Cooperation Laboratory on Signal Transduction，Eastern Hepatobiliary Surgery Hospital，Second Military Medical University，Shanghai 200438，China；National Center for Liver Cancer，Second Military Medical University，Shanghai 200438，China；International Cooperation Laboratory on Signal Transduction，Eastern Hepatobiliary Surgery Hospital，Second Military Medical University，Shanghai 200438，China；Fudan University Shanghai Cancer Center，Shanghai 200032，China；The Graduate School of Fujian Medical University，Fuzhou 350122，China；Center for Drug Safety Evaluation and Research，State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；Institute of Pathology，Southwest Hospital，Third Military Medical University(Army Medical University)，Chongqing 400038，China；Key Laboratory of Tumor Immunopathology，Ministry of Education of China，Chongqing 400038，China；China Military Institute of Chinese Materia，Fifth Medical Center of Chinese PLA General Hospital，Beijing 100039，China；Department of Health Statistics，Faculty of Medical Service，Second Military Medical University，Shanghai 200438，China；National Center for Liver Cancer，Second Military Medical University，Shanghai 200438，China）.Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood[J].药学学报(英文版),2022,第5期 Gan Wang，Min Zhang，Ping Meng，Chengbo Long，Xiaodong Luo，Xingwei Yang，Yunfei Wang，Zhiye Zhang，James Mwangi，Peter Muiruri Kamau，Zhi Dai，Zunfu Ke，Yi Zhang，Wenlin Chen，Xudong Zhao，Fei Ge，Qiumin Lv，Mingqiang Rong，Dongsheng Li，Yang Jin，Xia Sheng，Ren Lai（Key Laboratory of Animal Models and Human Disease Mechanisms，Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province，KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases，National Resource Center for Non-Human Primates，Kunming Primate Research Center，and National Research Facility for Phenotypic&Genetic Analysis of Model Animals(Primate Facility)，Kunming Institute of Zoology，Kunming 650107，China；Key Laboratory of Animal Models and Human Disease Mechanisms，Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province，KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases，National Resource Center for Non-Human Primates，Kunming Primate Research Center，and National Research Facility for Phenotypic&Genetic Analysis of Model Animals(Primate Facility)，Kunming Institute of Zoology，Kunming 650107，China；University of Chinese Academy of Sciences，Beijing 100049，China；State Key Laboratory of Phytochemistry and Plant Resources in West China，Kunming Institute of Botany，Chinese Academy of Sciences，Kunming 650201，China；Key Laboratory of Animal Models and Human Disease Mechanisms，Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province，KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases，National Resource Center for Non-Human Primates，Kunming Primate Research Center，and National Research Facility for Phenotypic&Genetic Analysis of Model Animals(Primate Facility)，Kunming Institute of Zoology，Kunming 650107，China；Institutes for Drug Discovery and Development，Chinese Academy of Sciences，Shanghai 201203，China；Key Laboratory of Animal Models and Human Disease Mechanisms，Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province，KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases，National Resource Center for Non-Human Primates，Kunming Primate Research Center，and National Research Facility for Phenotypic&Genetic Analysis of Model Animals(Primate Facility)，Kunming Institute of Zoology，Kunming 650107，China；University of Chinese Academy of Sciences，Beijing 100049，China；Sino-African Joint Research Center，Chinese Academy of Science，Wuhan 430074，China；Department of Pathology，First Affiliated Hospital，Sun Yat-sen University，Guangzhou 510080，China）.Anticarin-β shows a promising antiosteosarcoma effect by specifically inhibiting CCT4 to impair proteostasis[J].药学学报(英文版),2022,第5期 Zhenlu Xu，Dongyun Liu，Dong Liu，Xue Ren，Haibo Liu，Guihong Qi，Yue Zhou，Chongming Wu，Kui Zhu，Zhongmei Zou，Jing Yuan，Wenhan Lin，Peng Guo（Pharmacology and Toxicology Research Center，Institute of Medicinal Plant Development，Chinese Academy of Medical Sciences，Peking Union Medical College，Beijing 100193，China；Capital Institute of Pediatrics，Beijing 100020，China；State Key Laboratory of Natural and Biomimetic Drugs，Peking University，Beijing 100191，China；National Center for Veterinary Drug Safety Evaluation，College of Veterinary Medicine，China Agricultural University，Beijing 100193，China；Pharmacology and Toxicology Research Center，Institute of Medicinal Plant Development，Chinese Academy of Medical Sciences，Peking Union Medical College，Beijing 100193，China；Capital Institute of Pediatrics，Beijing 100020，China）.Equisetin is an anti-obesity candidate through targeting 11β-HSD1[J].药学学报(英文版),2022,第5期 Pedro Martín-Acosta，Qianli Meng，John Klimek，Ashok P.Reddy，Larry David，Stefanie Kaech Petrie，Bingbing X.Li，Xiangshu Xiao（Program in Chemical Biology，Department of Chemical Physiology and Biochemistry，Oregon Health&Science University，Portland，OR 97239，USA；Proteomics Shared Resource，Oregon Health&Science University，Portland，OR 97239，USA；Program in Chemical Biology，Department of Chemical Physiology and Biochemistry，Oregon Health&Science University，Portland，OR 97239，USA；Knight Cancer Institute，Oregon Health&Science University，Portland，OR 97239，USA；Knight Cancer Institute，Oregon Health&Science University，Portland，OR 97239，USA；Department of Neurology，Oregon Health&Science University，Portland，OR 97239，USA）.A clickable photoaffinity probe of betulinic acid identifies tropomyosin as a target[J].药学学报(英文版),2022,第5期 Wei Shi，Wanzhen Li，Jianxin Zhang，Tiehai Li，Yakai Song，Yue Zeng，Qian Dong，Zeng Lin，Likun Gong，Shuquan Fan，Feng Tang，Wei Huang（CAS Key Laboratory of Receptor Research，CAS Center for Excellence in Molecular Cell Science，Center for Biotherapeutics Discovery Research，Shanghai Institute of Materia Medica Chinese Academy of Sciences，Shanghai 201203，China；School of Pharmaceutical Science and Technology，Hangzhou Institute of Advanced Study，Hangzhou 310024，China；University of Chinese Academy of Sciences，Beijing 100049，China；School of Chinese Materia Medica，Nanjing University of Chinese Medicine，Nanjing 210023，China；CAS Key Laboratory of Receptor Research，CAS Center for Excellence in Molecular Cell Science，Center for Biotherapeutics Discovery Research，Shanghai Institute of Materia Medica Chinese Academy of Sciences，Shanghai 201203，China；School of Life Science，Liaocheng University，Liaocheng 252059，China；CAS Key Laboratory of Receptor Research，CAS Center for Excellence in Molecular Cell Science，Center for Biotherapeutics Discovery Research，Shanghai Institute of Materia Medica Chinese Academy of Sciences，Shanghai 201203，China；School of Pharmaceutical Science and Technology，Hangzhou Institute of Advanced Study，Hangzhou 310024，China；CAS Key Laboratory of Receptor Research，CAS Center for Excellence in Molecular Cell Science，Center for Biotherapeutics Discovery Research，Shanghai Institute of Materia Medica Chinese Academy of Sciences，Shanghai 201203，China；School of Pharmaceutical Science and Technology，Hangzhou Institute of Advanced Study，Hangzhou 310024，China；University of Chinese Academy of Sciences，Beijing 100049，China；School of Chinese Materia Medica，Nanjing University of Chinese Medicine，Nanjing 210023，China）.One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates[J].药学学报(英文版),2022,第5期 Dong Liang，Chen Yu，Zhao Ma，Xingye Yang，Zhenzhen Li，Xuhui Dong，Xiaojun Qin，Lupei Du，Minyong Li（Key Laboratory of Chemical Biology(MOE)，School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University，Jinan 250012，China）.Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning[J].药学学报(英文版),2022,第5期 Nazi Song，Hongjiao Xu，Jiahua Liu，Qian Zhao，Hui Chen，Zhibin Yan，Runling Yang，Zhiteng Luo，Qi Liu，Jianmei Ouyang，Shuohan Wu，Suijia Luo，Shuyin Ye，Runfeng Lin，Xi Sun，Junqiu Xie，Tian Lan，Zhongdao Wu，Rui Wang，Xianxing Jiang（School of Pharmaceutical Sciences，Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery，Sun Yat-sen University，Guangzhou 510006，China；Department of Parasitology of Zhongshan School of Medicine，Sun Yat-sen University，Guangzhou 510006，China；Key Laboratory of Tropical Disease Control，Ministry of Education，Sun Yat-sen University，Guangzhou 510006，China；Provincial Engineering Technology Research Center for Biological Vector Control，Sun Yat-sen University，Guangzhou 510006，China；Research Unit of Peptide Science，Chinese Academy of Medical Sciences，Lanzhou 730000，China；Key Laboratory of Preclinical Study for New Drugs of Gansu Province，School of Basic Medical Sciences，Lanzhou University，Lanzhou 730000，China；Shenzhen Turier Biotech.Co.，Ltd.，Shenzhen 518118，China；Guangdong Pharmaceutical University，Guangzhou 510006，China）.Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis[J].药学学报(英文版),2022,第5期 Wei Gao，Hongxiang Hu，Lipeng Dai，Miao He，Hebao Yuan，Huixia Zhang，Jinhui Liao，Bo Wen，Yan Li，Maria Palmisano，Mohamed Dit Mady Traore，Simon Zhou，Duxin Sun（Department of Pharmaceutical Sciences，College of Pharmacy，University of Michigan，Ann Arbor MI 48109，USA；Translational Development and Clinical Pharmacology，Bristol Myers Squibb，Summit，NJ 07920，USA）.Structure-tissue exposure/selectivity relationship(STR) correlates with clinical efficacy/safety[J].药学学报(英文版),2022,第5期 Wufa Fan，Haixia Peng，Zhou Yu，Luting Wang，Haisheng He，Yuhua Ma，Jianping Qi，Yi Lu，Wei Wu（Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University，Shanghai 201203，China；Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University，Shanghai 201203，China；Key Laboratory for Tibet Plateau Phytochemistry of Qinghai Province，School of Pharmacy，Qinghai Nationalities University，Xining 810007，China；Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University，Shanghai 201203，China；Shanghai Skin Disease Hospital，Tongji University School of Medicine，Shanghai 200443，China；Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University，Shanghai 201203，China；Center for Medical Research and Innovation，Shanghai Pudong Hospital，Fudan University Pudong Medical Center，Shanghai 201399，China；Shanghai Skin Disease Hospital，Tongji University School of Medicine，Shanghai 200443，China）.The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers[J].药学学报(英文版),2022,第5期 Siping Liang，Jiaying Li，Zhengyu Zou，Miao Mao，Siqi Ming，Fan Lin，Ziyan Zhang，Can Cao，Jinyu Zhou，Yuanqing Zhang，Jiaping Li，Minhao Wu（Zhongshan School of Medicine；Department of Laboratory Medicine；Guangdong Key Laboratory of Chiral Molecule and Drug Discovery；Department of Interventional Oncology）.Tetrahedral DNA nanostructures synergize with MnO₂ to enhance antitumor immunity via promoting STING activation and M1 polarization[J].药学学报(英文版),2022,第5期 Weiyi Xia，Chao Li，Qinjun Chen，Jiancheng Huang，Zhenhao Zhao，Peixin Liu，Kai Xu，Lei Li，Fangyuan Hu，Shujie Zhang，Tao Sun，Chen Jiang，Chen Zhao（Department of Ophthalmology and Vision Science，Eye&ENT Hospital，Shanghai Medical School，Fudan University，Shanghai 200031，China；Key Laboratory of Smart Drug Delivery，Ministry of Education，Department of Pharmaceutics，School of Pharmacy，Fudan University，Shanghai 201203，China）.Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation[J].药学学报(英文版),2022,第5期 Jie Chang，Ruirui Yang，Lifan Chen，Zisheng Fan，Jingyi Zhou，Hao Guo，Yinghui Zhang，Yadan Liu，Guizhen Zhou，Keke Zhang，Kaixian Chen，Hualiang Jiang，Mingyue Zheng，Sulin Zhang（School of Chinese Materia Medica，Nanjing University of Chinese Medicine，Nanjing 210023，China；Drug Discovery and Design Center State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；Drug Discovery and Design Center State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；University of Chinese Academy of Sciences，Beijing 100049，China；Shanghai Institute for Advanced Immunochemical Studies，and School of Life Science and Technology，ShanghaiTech University，Shanghai 200031，China；Drug Discovery and Design Center State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；University of Chinese Academy of Sciences，Beijing 100049，China；Drug Discovery and Design Center State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；University of Chinese Academy of Sciences，Beijing 100049，China；School of Chinese Materia Medica，Nanjing University of Chinese Medicine，Nanjing 210023，China；Drug Discovery and Design Center State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；University of Chinese Academy of Sciences，Beijing 100049，China；School of Chinese Materia Medica，Nanjing University of Chinese Medicine，Nanjing 210023，China；Shanghai Institute for Advanced Immunochemical Studies，and School of Life Science and Technology，ShanghaiTech University，Shanghai 200031，China）.Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer[J].药学学报(英文版),2022,第5期 Dandan Shen，Bo Wang，Ya Gao，Lijuan Zhao，Yaping Bi，Jinge Zhang，Ning Wang，Huiqin Kang，Jingru Pang，Ying Liu，Luping Pang，Zhe-Sheng Chen，Yi-Chao Zheng，Hong-Min Liu（Key Laboratory of Advanced Drug Preparation Technologies，Ministry of Education of China；Collaborative Innovation Center of New Drug Research and Safety Evaluation，Zhengzhou University，Zhengzhou 450052，China；Key Laboratory of Advanced Drug Preparation Technologies，Ministry of Education of China；Collaborative Innovation Center of New Drug Research and Safety Evaluation，Zhengzhou University，Zhengzhou 450052，China；Key Laboratory of Henan Province for Drug Quality and Evaluation，Institute of Drug Discovery and Development，School of Pharmaceutical Sciences，Zhengzhou University，Zhengzhou 450052，China；Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John，s University，Queens，NY 11439，USA；State Key Laboratory of Esophageal Cancer Prevention&Treatment，Academy of Medical Sciences，Zhengzhou University，Zhengzhou 450052，China）.Detailed resume of RNA m⁶A demethylases[J].药学学报(英文版),2022,第5期 Qiuyi Li，Cheng Chen，Jinxia Kong，Lian Li，Junlin Li，Yuan Huang（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University，Chengdu 610041，China）.Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade[J].药学学报(英文版),2022,第5期 Lihuan Shang，Xue Jiang，Ting Yang，Hongbo Xu，Qi Xie，Mei Hu，Conglian Yang，Li Kong，Zhiping Zhang（Tongji School of Pharmacy，Huazhong University of Science and Technology，Wuhan 430030，China；Tongji School of Pharmacy，Huazhong University of Science and Technology，Wuhan 430030，China；Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation，Medical Research Center，Sun Yat-sen Memorial Hospital，Sun Yat-sen University，Guangzhou 510120，China；Tongji School of Pharmacy，Huazhong University of Science and Technology，Wuhan 430030，China；National Engineering Research Center for Nanomedicine，Huazhong University of Science and Technology，Wuhan 430030，China；Hubei Engineering Research Centre for Novel Drug Delivery System，Huazhong University of Science and Technology，Wuhan 430030，China）.Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment[J].药学学报(英文版),2022,第5期 Abi Maharjan，Hongyu Sun，Zeying Cao，Ke Li，Jinping Liu，Jun Liu，Tiqiao Xiao，Guanyun Peng，Junqiu Ji，Peter York，Balmukunda Regmi，Xianzhen Yin，Jiwen Zhang，Li Wu（Center for Drug Delivery System，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；School of Pharmacy，Key Laboratory of Molecular Pharmacology and Drug Evaluation，Ministry of Education，Yantai University，Yantai 264005，China；University of Chinese Academy of Sciences，Beijing 100049，China；Center for Drug Delivery System，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients，National Institutes for Food and Drug Control，Beijing 100050，China；Center for Drug Delivery System，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；University of Chinese Academy of Sciences，Beijing 100049，China；University of Chinese Academy of Sciences，Beijing 100049，China；Shanghai Synchrotron Radiation Facility/Zhangjiang Lab，Shanghai Advanced Research Institute，Chinese Academy of Sciences，Shanghai 201204，China；Hefei Lifeon Medication Group，Hefei 230088，China；Center for Drug Delivery System，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；Center for MOST and Image Fusion Analysis，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201210，China；Shanghai Synchrotron Radiation Facility/Zhangjiang Lab，Shanghai Advanced Research Institute，Chinese Academy of Sciences，Shanghai 201204，China；Center for MOST and Image Fusion Analysis，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201210，China；Center for Drug Delivery System，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；Maharajgung Medical Campus，Institute of Medicine，Tribhuvan University，Kathmandu 44606，Nepal；Center for Drug Delivery System，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；University of Chinese Academy of Sciences，Beijing 100049，China；NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients，National Institutes for Food and Drug Control，Beijing 100050，China；Center for Drug Delivery System，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；School of Pharmacy，Key Laboratory of Molecular Pharmacology and Drug Evaluation，Ministry of Education，Yantai University，Yantai 264005，China）.Redefinition to bilayer osmotic pump tablets as subterranean river system within mini-earth via three-dimensional structure mechanism[J].药学学报(英文版),2022,第5期 Elisa Rioja-Blanco，Irene Arroyo-Solera，Patricia álamo，Isolda Casanova，Alberto Gallardo，Ugutz Unzueta，Naroa Serna，Laura Sánchez-García，Miquel Quer，Antonio Villaverde，Esther Vázquez，Ramon Mangues，Lorena Alba-Castellón，Xavier León（Institut d'Investigació Biomèdica Sant Pau(ⅡB-Sant Pau)，Barcelona 08041，Spain；Institut de Recerca contra la Leucèmia Josep Carreras，Barcelona 08025，Spain；Institut d'Investigació Biomèdica Sant Pau(ⅡB-Sant Pau)，Barcelona 08041，Spain；Institut de Recerca contra la Leucèmia Josep Carreras，Barcelona 08025，Spain；CIBER de Bioingenienía，Biomateriales y Nanomedicina(CIBER-BBN)，Madrid 28029，Spain；Institut d'Investigació Biomèdica Sant Pau(ⅡB-Sant Pau)，Barcelona 08041，Spain；Department of Pathology，Hospital de la Santa Creu i Sant Pau，Barcelona 08041，Spain；CIBER de Bioingenienía，Biomateriales y Nanomedicina(CIBER-BBN)，Madrid 28029，Spain；Institut de Biotecnologia i de Biomedicina，Universitat Autònoma de Barcelona，Bellaterra 08193，Spain；Departament de Genètica i de Microbiologia，Universitat Autònoma de Barcelona，Bellaterra 08193，Spai；CIBER de Bioingenienía，Biomateriales y Nanomedicina(CIBER-BBN)，Madrid 28029，Spain；Institut de Biotecnologia i de Biomedicina，Universitat Autònoma de Barcelona，Bellaterra 08193，Spain；Departament de Genètica i de Microbiologia，Universitat Autònoma de Barcelona，Bellaterra 08193，Spain；CIBER de Bioingenienía，Biomateriales y Nanomedicina(CIBER-BBN)，Madrid 28029，Spain；Department of Otorhinolaryngology，Hospital de la Santa Creu i Sant Pau，Barcelona 08041，Spain）.Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4⁺ head and neck squamous cell carcinoma tumors[J].药学学报(英文版),2022,第5期 Di Zhu，Yu Lu，Lin Gui，Wenjing Wang，Xi Hu，Su Chen，Yanming Wang，Yuji Wang（Department of Medicinal Chemistry，College of Pharmaceutical Sciences of Capital Medical University，Beijing 100069，China；Beijing Area Major Laboratory of Peptide and Small Molecular Drugs，Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China，Beijing Laboratory of Biomedical Materials，Beijing 100069，China；Beijing Institute of Hepatology，Beijing Youan Hospital，Capital Medical University，Beijing 100069，China；Quantum Design China Ltd.，Universal Business Park，Beijing 100015，China；Laboratory of Biomaterials and Biomechanics，Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction，School of Stomatology，Capital Medical University，Beijing 100050，China；School of Life Sciences，Henan University，Kaifeng 475004，China）.Self-assembling，pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment[J].药学学报(英文版),2022,第5期 Zhuo-Xun Wu，Qiu-Xu Teng，Yuqi Yang，Nikita Acharekar，Jing-Quan Wang，Min He，Sabesan Yoganathan，Jun Lin，Jian Wang，Zhe-Sheng Chen（Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John's University，Queens，NY 11439，USA；Department of Radiotherapy，the Affiliated Jiangvin People's Hospital of Nantong University，Jiangyin 214400，China；Department of Anesthesiology，Stony Brook University Health Sciences Center Stony Brook，NY 11794，USA）.MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter：In vitro and in vivo study[J].药学学报(英文版),2022,第5期 Songli Wang，Ruifeng Wang，Nana Meng，Linwei Lu，Jun Wang，Jianfen Zhou，Jiasheng Lu，Qianzhu Xu，Cao Xie，Changyou Zhan，Yao Li，Yang Yu，Weiyue Lu，Min Liu（Department of Pharmaceutics；The Department of Integrative Medicine；Department of Pharmacology；The National Facility for Protein Science in Shanghai（NFPS）；State Key Laboratory of Medical Neurobiology and the Collaborative Innovation Center for Brain Science and Department of Pharmacology；Minhang Branch）.Engineered platelets-based drug delivery platform for targeted thrombolysis[J].药学学报:英文版,2022,第4期 Lei Wu，Lingling Wang，Xi Liu，Yuli Bai，Ruinan Wu，Xiang Li，Yutong Mao，Ling Zhang，Yongxiang Zheng，Tao Gong，Zhirong Zhang，Yuan Huang（Key Laboratory of Drug Targeting and Drug Delivery System；Sichuan University；Sichuan University West China School of Pharmacy）.Milk-derived exosomes exhibit versatile effects for improved oral drug delivery[J].药学学报:英文版,2022,第4期 Yuyun Tang，Jinchao Gao，Tao Wang，Qian Zhang，Antian Wang，Meng Huang，Renhe Yu，Hongzhuan Chen，Xiaoling Gao（Department of Pharmacology and Chemical Biology；Department of Geriatric Psychiatry；Institute of Interdisciplinary Integrative Biomedical Research）.The effect of drug loading and multiple administration on the protein corona formation and brain delivery property of PEG-PLA nanoparticles[J].药学学报:英文版,2022,第4期 Yang He，Yuefei Fang，Meng Zhang，Yuge Zhao，Bin Tu，Mingjie Shi，Bahtiyor Muhitdinov，Akmal Asrorov，Qin Xu，Yongzhuo Huang（State Key Laboratory of Drug Research；University of Chinese Academy of Sciences；Zhongshan Institute for Drug Discovery；Department of Pharmacy；Artemisinin Research Center；Women’s Hospital；Institute of Bioorganic Chemistry；National Medical Products Administration）.Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona[J].药学学报:英文版,2022,第4期 Boyi Niu，Yixian Zhou，Kaixin Liao，Ting Wen，Sixian Lao，Guilan Quan，Xin Pan，Chuanbin Wu（School of Pharmaceutical Sciences；College of Pharmacy）.“Pincer movement”：Reversing cisplatin resistance based on simultaneous glutathione depletion and glutathione S-transferases inhibition by redox-responsive degradable organosilica hybrid nanoparticles[J].药学学报:英文版,2022,第4期 Rong Xiang，Zhengsen Yu，Yang Wang，Lili Wang，Shanshan Huo，Yanbai Li，Ruiying Liang，Qinghong Hao，Tianlei Ying，Yaning Gao，Fei Yu，Shibo Jiang（College of Life Sciences；Research Center of Chinese Jujube；Key Laboratory of Medical Molecular Virology（MOE/NHC/CAMS）；Beijing Pharma and Biotech Center）.Recent advances in developing small-molecule inhibitors against SARS-CoV-2[J].药学学报:英文版,2022,第4期 Xuejing Shao，Yingqian Chen，Wei Wang，Wenxin Du，Xingya Zhang，Minyi Cai，Shaowei Bing，Ji Cao，Xiaojun Xu，Bo Yang，Qiaojun He，Meidan Ying（Institute of Pharmacology and Toxicology；Children’s Hospital；Cancer Center；Innovation Institute for Artificial Intelligence in Medicine）.Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells[J].药学学报:英文版,2022,第4期首页上一页 4 5 6 7 8 下一页尾页共有11页，转到页

期刊文章列表